From Protein Communication to Drug Discovery

被引:4
|
作者
Persico, Marco [1 ]
Di Dato, Antonio [1 ]
Orteca, Nausicaa [1 ]
Fattorusso, Caterina [1 ]
Novellino, Ettore [1 ]
Andreoli, Mirko [2 ]
Ferlini, Cristiano [2 ]
机构
[1] Univ Naples Federico II, Dept Pharm, I-80131 Naples, Italy
[2] Danbury Hosp Res Inst, Danbury, CT 06810 USA
关键词
Drug discovery; Hot spots; Inter-protein communication; Intra-protein communication; Natural products; Protein interaction domains; Short linear motifs; GUANYLATE-BINDING PROTEIN-1; ANTICANCER AGENTS; GTP HYDROLYSIS; HOT-SPOTS; HUMAN CHOLINESTERASES; NETWORK PHARMACOLOGY; BIOSYNTHETIC-ENZYMES; THERAPEUTIC TARGETS; NUCLEOTIDE-BINDING; REFINED STRUCTURE;
D O I
10.2174/1568026615666150519102257
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The majority of functionally important biological processes are regulated by allosteric communication within individual proteins and across protein complexes. The proteins controlling these communication networks respond to changes in the cellular environment by switching between different conformational states. Targeting the interface residues mediating these processes through the rational identification of molecules modulating or mimicking their effects holds great therapeutic potential. Protein-protein interactions (PPIs) have shown to have a high degree of plasticity since they occur through small regions, called hot spots, which are included in binding surfaces or in binding clefts of the proteins and are characterized by a high degree of complementarity. This prompted several researchers to compare the protein structure to human grammar proposing terms like "protein language". The decoding of this language represent a new paradigm not only to clarify the dynamics of many biological processes but also to improve the opportunities in drug discovery. In this review, we try to give an overview on intra-molecular and inter-molecular protein communication mechanisms describing the protein interaction domains (PIDs) and short linear motifs (SLiMs), which delineate the authentic syntactic and semantic units in a protein. Moreover, we illustrate some novel approaches performed on natural compounds and on synthetic derivatives aimed at developing new classes of potential drugs able to interfere with intra-molecular and inter-molecular protein communication.
引用
收藏
页码:2019 / 2031
页数:13
相关论文
共 50 条
  • [21] Implications of protein flexibility for drug discovery
    Teague, SJ
    NATURE REVIEWS DRUG DISCOVERY, 2003, 2 (07) : 527 - 541
  • [22] Targeted protein degradation and drug discovery
    Naito, Mikihiko
    JOURNAL OF BIOCHEMISTRY, 2022, : 61 - 69
  • [23] Protein Interfaces as Targets in Drug Discovery
    Fattorusso, Caterina
    Persico, Marco
    CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2015, 15 (20) : 2003 - 2004
  • [24] Protein-RNA interactions: from mass spectrometry to drug discovery
    Steinmetz, Benjamin
    Smok, Izabela
    Bikaki, Maria
    Leitner, Alexander
    ESSAYS IN BIOCHEMISTRY, 2023, 67 (02) : 175 - 186
  • [25] Protein N terminal modifications: from chemical biology to drug discovery
    Tate, E. W.
    FEBS OPEN BIO, 2018, 8 : 72 - 73
  • [26] Mining protein lists from proteomics studies: applications for drug discovery
    Antonov, Alexey V.
    EXPERT OPINION ON DRUG DISCOVERY, 2010, 5 (04) : 323 - 331
  • [27] Interaction networks: From protein functions to drug discovery. A review
    Chautard, E.
    Thierry-Mieg, N.
    Ricard-Blum, S.
    PATHOLOGIE BIOLOGIE, 2009, 57 (04): : 324 - 333
  • [28] Stabilization of protein-protein interactions in drug discovery
    Andrei, Sebastian A.
    Sijbesma, Eline
    Hann, Michael
    Davis, Jeremy
    O'Mahony, Gavin
    Perry, Matthew W. D.
    Karawajczyk, Anna
    Eickhoff, Jan
    Brunsveld, Luc
    Doveston, Richard G.
    Milroy, Lech-Gustav
    Ottmann, Christian
    EXPERT OPINION ON DRUG DISCOVERY, 2017, 12 (09) : 925 - 940
  • [30] The communication barrier: drug discovery's final frontier?
    Nature Reviews Drug Discovery, 2004, 3 : 191 - 191